DNA Nanorobots That Cut Off Tumour Blood Supply: The 2018 Study

Facebook ↗WhatsApp ↗
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors

Can a tiny robot made of DNA kill a cancer? In a 2018 study, a team from Arizona State University (ASU) and China's National Center for Nanoscience and Technology (NCNST) built a DNA structure that travelled through the bloodstream of mice, found the blood vessels feeding tumours and made the blood inside them clot. Starved of supply, many tumours shrank or stopped growing. It was a striking result, but it was an animal experiment, not a cure that patients can use today.

Here is what the "nanorobot" actually is, how it worked, what the numbers showed and why a mouse result is only the first step on a long road.

What the researchers built

The device is made with a technique called DNA origami. Instead of using DNA to store genes, scientists use it as a building material. A long single strand of DNA is folded into a chosen shape by hundreds of short "staple" strands that stick to set places along it. The method was developed by Paul Rothemund at Caltech and featured on the cover of Nature in March 2006.

For this project, the team made a flat rectangle of DNA about 90 by 60 nanometres. That is roughly a thousand times thinner than a human hair. Onto that sheet they attached about four molecules of thrombin, the enzyme your body uses to form blood clots. The sheet was then rolled into a hollow tube, with the thrombin hidden inside.

The outside of the tube carried a DNA aptamer: a short strand that grips one particular protein. Its target was nucleolin, which is found in high amounts on the inner lining of blood vessels that feed tumours, and much less on healthy vessels. The aptamer did two jobs. It steered the tube to tumour vessels, and when it latched onto nucleolin, it acted as a trigger that opened the tube and exposed the thrombin.

"Robot" may sound like gears and motors. Here it means a structure that senses a molecular signal and then changes shape to do one task without outside control. Hao Yan of ASU's Biodesign Institute, a co-lead of the project, described it as the first fully autonomous DNA robotic system for targeted cancer therapy.

Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors

Diagram of the DNA nanorobot: a rolled DNA sheet with thrombin inside and tumour-targeting DNA on the outside.

How cutting off blood supply attacks a tumour

A solid tumour that grows beyond a few millimetres needs its own blood vessels to bring oxygen and nutrients. Doctors have tried to exploit this for decades, mostly with drugs that block new vessel growth. The ASU and NCNST team took a more direct route: block the vessels that already exist.

When thrombin is released inside a tumour vessel, it sets off clotting right there. The clot works like a plug. Tissue downstream loses its supply and dies, a process the researchers compared to a small heart attack inside the tumour. Because all solid tumours depend on blood vessels, Yan argued that the same approach might work across many cancer types.

The obvious danger is clotting in the wrong place. A stray clot in the brain could cause a stroke, and one in the lungs could be deadly. That is why the targeting and the trigger matter so much: the thrombin is supposed to stay locked away until the tube reaches a tumour vessel.

What the experiments found

The results were published in Nature Biotechnology in 2018 under the title "A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo", with Suping Li as first author. The team grew tumours in mice using human cancer cells and then injected the nanorobots into a vein.

  • Speed: the nanorobots gathered around tumours within hours. By 24 hours, tumour blood supply was blocked and tumour tissue was damaged, and most nanorobots had already been broken down and cleared.
  • Clotting: by day two there was advanced thrombosis, and by day three clots were seen in all tumour vessels examined.
  • Cancer types: the approach was tested in mouse models of breast cancer, melanoma, ovarian cancer and lung cancer. In a primary lung cancer model, tumours shrank after two weeks of treatment.
  • Melanoma: three of the eight treated mice saw their tumours disappear completely, and median survival rose from 20.5 days to 45 days. The treatment also appeared to prevent the cancer spreading.

The team also checked safety. Yuliang Zhao of NCNST, who led the international team, said the nanorobot was "safe and immunologically inert for use in normal mice" and in Bama miniature pigs, with no detectable change in normal blood clotting. The researchers found no sign of the nanorobots reaching the brain.

Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors

The study's results come from laboratory mice, with extra safety checks in miniature pigs.

Why this is not yet a cure

Headlines in 2018 asked whether this was finally the cure for cancer. The honest answer is no, or at least not yet. Many treatments that work brilliantly in mice fail in people, because a mouse tumour grown from injected cells is much simpler than a cancer that has developed over years in a human body.

Several big questions remain open:

  • Dose and safety in people. Pigs are closer to humans than mice, but human safety can only be shown in carefully staged clinical trials.
  • Real tumours vary. Human tumours differ in how many blood vessels they have and how much nucleolin those vessels carry. Some cells at the tumour edge can survive on nearby healthy vessels.
  • Stability. DNA structures can fall apart in the body, because enzymes in blood digest DNA. Making origami that survives long enough, but not too long, is an active research area.
  • Manufacturing. Folding DNA precisely is easy in a lab and much harder at the scale and purity a medicine needs.

At the time, Yan and his colleagues said they were looking for clinical partners to take the work further. They also suggested that different nanorobots carrying different payloads could one day be combined. As far as public records show, no DNA-origami cancer treatment has been approved for patients.

Where DNA nanomedicine stands

The 2018 study is part of a wider push to use DNA as a delivery vehicle. Researchers at Harvard's Wyss Institute built an earlier DNA "box" that opened with an aptamer lock to release its cargo near leukaemia and lymphoma cells in lab tests. Other teams have packed chemotherapy drugs such as doxorubicin into DNA origami, and in mouse studies these shapes shrank tumours more than the free drug did.

What makes DNA attractive is that it is programmable. Change the sequence of a few strands and you change the shape, the target or the trigger. The same basic tube could, in principle, carry a different drug to a different tissue. That flexibility is exactly why scientists remain excited, even though most uses are still at the concept or testing stage.

Common myths about cancer nanorobots

"Nanorobots swim around hunting cancer cells." These structures have no motors and cannot steer. They drift in the blood and stick where their target protein is found.

"It destroys cancer cells directly." It does not attack the cancer cells at all. It blocks their blood supply and lets the tissue die from lack of oxygen and nutrients.

"It worked, so it will be available soon." Even promising therapies usually take many years to move from animal studies through clinical trials, and many never make it.

"One injection cleared all tumours." In the melanoma group, complete regression happened in three of eight mice. That is impressive for a single experiment, but most treated animals still had tumours.

If you or someone you love is dealing with cancer, talk to a doctor or an oncology team about proven options and clinical trials that may be open to you. Headlines about laboratory studies are a reason for hope, not a reason to change a treatment plan.

Images from the original story

The stock photographs below accompanied early coverage of the study. They are general medical images, not pictures from the experiment itself.

Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors
Scientists Created The First Nanorobots Programmed To Shrink Cancer Tumors

Image source: Getty Images

Sources: Li et al., Nature Biotechnology 36, 258–264 (2018); ASU News, 12 February 2018; Wikipedia: DNA origami; first reported to our readers via Express.co.uk.

COMMENTS

BLOGGER: 1
  1. wow! quite an advancement! How long before human trials?

    ReplyDelete